Summary

Science Corporation CEO Max Hodak announced that the company has implanted its vision-restoring chip , PRIMA, into its first patient with Stargardt disease, an inherited eye disease that gradually destroys central vision. Hodak, the former president and co-founder of Neuralink, the brain implant company, explained on stage at TechCrunch Disrupt how the company’s work with PRIMA fits into its broader pursuit of a novel brain-computer interface (BCI). “The retina is part of the central nervous system,” Hodak said on stage.

AI summaries can be wrong sometimes—always verify important details using the source article.